The SiVEC delivery system is extremely versatile. Partners can use our platform technology as a tool to build their own therapeutic pipelines for distinct disease indications using a variety of nucleic acid therapeutic approaches, including gene editing, mRNA, siRNA, and protein replacement.

SiVEC Biotechnologies is excited to partner with CDMOs, CROs, and biopharma companies developing nucleic acid and gene therapies who need an alternative delivery system

Please contact us for more information about current opportunities.